AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
AAPL   382.73 (+0.36%)
MSFT   214.32 (+0.70%)
FB   244.50 (+0.38%)
GOOGL   1,518.66 (+1.00%)
AMZN   3,182.63 (+3.29%)
NVDA   420.36 (+2.87%)
CGC   16.02 (-1.90%)
GE   6.58 (-4.08%)
TSLA   1,394.28 (+2.08%)
AMD   57.26 (+7.17%)
T   29.54 (-3.02%)
ACB   11.77 (-3.21%)
BAC   22.77 (-1.43%)
BA   173.28 (-3.78%)
Log in

OTCMKTS:ALGXYALGAE TEC LTD/S Stock Price, Forecast & News

$0.0023
0.00 (0.00 %)
(As of 06/29/2020)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.26
Volume10 shs
Average Volume1 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta165.87
Affinity Energy and Health Limited operates as a plant-based health and wellbeing company in Australia, India, and the United States. It engages in developing technology to produce commercial quantities of algae and medicinal cannabis for supply to algae-based nutraceuticals, animal feed and aquaculture, medicinal cannabis, and biofuels markets. The company offers FeedMe Algae, an algae-based aqua feed; and algae-based biofuels. Affinity Energy and Health Limited was founded in 2007 and is based in Subiaco, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars


Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ALGXY
CUSIPN/A
CIKN/A
Phone61-8-9380-6790

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.05 million

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ALGXY News and Ratings via Email

Sign-up to receive the latest news and ratings for ALGXY and its competitors with MarketBeat's FREE daily newsletter.

ALGAE TEC LTD/S (OTCMKTS:ALGXY) Frequently Asked Questions

How has ALGAE TEC LTD/S's stock been impacted by COVID-19 (Coronavirus)?

ALGAE TEC LTD/S's stock was trading at $0.0017 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ALGXY shares have increased by 35.3% and is now trading at $0.0023. View which stocks have been most impacted by Coronavirus.

Has ALGAE TEC LTD/S been receiving favorable news coverage?

Press coverage about ALGXY stock has trended somewhat negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. ALGAE TEC LTD/S earned a daily sentiment score of -1.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. View the latest news about ALGAE TEC LTD/S.

Who are some of ALGAE TEC LTD/S's key competitors?

Who are ALGAE TEC LTD/S's key executives?

ALGAE TEC LTD/S's management team includes the following people:
  • Mr. Malcolm Raymond Scott James BBusS, CPA, FAICD, MAusIMM, Exec. Chairman & MD (Age 63)
  • Mr. Garnet Earl McConchie, Exec. Director (Age 68)
  • Mr. James Vosper, Medical Marijuana Consultant

What is ALGAE TEC LTD/S's stock symbol?

ALGAE TEC LTD/S trades on the OTCMKTS under the ticker symbol "ALGXY."

How do I buy shares of ALGAE TEC LTD/S?

Shares of ALGXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ALGAE TEC LTD/S's stock price today?

One share of ALGXY stock can currently be purchased for approximately $0.00.

What is ALGAE TEC LTD/S's official website?

The official website for ALGAE TEC LTD/S is www.affinityenergyandhealth.com.au.

How can I contact ALGAE TEC LTD/S?

ALGAE TEC LTD/S's mailing address is Unit 2 100 Railway Road, Subiaco C3, 6008. The company can be reached via phone at 61-8-9380-6790.

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.